rs147519875
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001365999.1(SZT2):c.368A>G(p.His123Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000336 in 1,613,818 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001365999.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152128Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000171 AC: 43AN: 251186Hom.: 0 AF XY: 0.000177 AC XY: 24AN XY: 135742
GnomAD4 exome AF: 0.000350 AC: 512AN: 1461690Hom.: 0 Cov.: 30 AF XY: 0.000331 AC XY: 241AN XY: 727146
GnomAD4 genome AF: 0.000197 AC: 30AN: 152128Hom.: 0 Cov.: 32 AF XY: 0.000242 AC XY: 18AN XY: 74312
ClinVar
Submissions by phenotype
not provided Uncertain:4
This sequence change replaces histidine, which is basic and polar, with arginine, which is basic and polar, at codon 123 of the SZT2 protein (p.His123Arg). This variant is present in population databases (rs147519875, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with SZT2-related conditions. ClinVar contains an entry for this variant (Variation ID: 411939). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0". The arginine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
- -
In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Developmental and epileptic encephalopathy, 18 Uncertain:1
- -
not specified Uncertain:1
Variant summary: SZT2 c.368A>G (p.His123Arg) results in a non-conservative amino acid change in the encoded protein sequence. Three of four in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00017 in 251186 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in SZT2 causing Early Infantile Epileptic Encephalopathy 18, allowing no conclusion about variant significance. To our knowledge, no occurrence of c.368A>G in individuals affected with Early Infantile Epileptic Encephalopathy 18 and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 411939). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Inborn genetic diseases Uncertain:1
The p.H123R variant (also known as c.368A>G), located in coding exon 4 of the SZT2 gene, results from an A to G substitution at nucleotide position 368. The histidine at codon 123 is replaced by arginine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at